Alpha Cognition vs Caribou Biosciences
Caribou Biosciences reported revenue of $11 million in fiscal 2025, about the same as Alpha Cognition's $10 million in fiscal 2025. Alpha Cognition had an operating margin of -221.7%, against -1329.4% at Caribou Biosciences. Free cash flow was −$21 million at Alpha Cognition and −$112 million at Caribou Biosciences.
Side by side
| Alpha Cognition | Caribou Biosciences | |
|---|---|---|
| Latest fiscal year | FY2025, Dec 31, 2025 | FY2025, Dec 31, 2025 |
| Revenue | $10M | $11M |
| Revenue growth | — | 11.7% |
| Revenue growth a year, last 5 years | — | −2.0% |
| Gross margin | 94.1% | — |
| Operating margin | −221.7% | −1,329.4% |
| Net margin | −202.2% | −1,327.4% |
| Free cash flow | −$21M | −$112M |
| Free cash flow margin | −202.3% | −1,006.8% |
| Return on capital | — | — |
| Net debt to EBITDA | — | — |
| Dividends and buybacks | $0M | $0M |
| Change in diluted share count | 143.9% | 3.4% |
| Last close | $8.85 | $0.31 |
| P/E at the last close | — | — |
| Insider trades, last 12 months | bought $7.6 million, sold $0 | sold $33,875 |
| Piotroski F-score | — | — |
Amounts in each company's own currency, US$ unless marked (a foreign company may report in another), each company's latest fiscal year from its 10-K, or 20-F or 40-F for a foreign company. Growth rates compare with the year before; the five-year rate is the average a year. Free cash flow is cash from operations minus capital spending; return on capital is after-tax operating income over the money invested in the business; P/E is the last close over the latest earnings per share. Banks are measured differently (return on equity, efficiency ratio), so some rows apply to one company only.
Ten years
Revenue
US$ billions, fiscal years
Alpha CognitionCaribou Biosciences
Operating margin
Percent of revenue
Alpha CognitionCaribou Biosciences
Free cash flow
US$ billions. Cash from operations minus capital expenditure.
Alpha CognitionCaribou Biosciences
Source: the companies' Form 10-K filings, from SEC EDGAR, and the last close. For information only, not investment advice: the figures describe results, not which company is the better investment. The Filing Desk is not affiliated with either company. Full figures on the Alpha Cognition and Caribou Biosciences pages.